Bausch Health Companies (TSE:BHC) Stock Price Down 8.8% – Should You Sell?

Bausch Health Companies Inc. (TSE:BHC) shares fell 8.8% during trading on Friday . The company traded as low as C$8.11 and last traded at C$8.27. 366,705 shares were traded during mid-day trading, a decline of 7% from the average session volume of 394,074 shares. The stock had previously closed at C$9.07.

Analyst Upgrades and Downgrades

BHC has been the topic of several analyst reports. Barclays upgraded Bausch Health Companies to a “hold” rating in a report on Monday, December 8th. Raymond James Financial upgraded shares of Bausch Health Companies to a “hold” rating in a research note on Monday, December 15th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Bausch Health Companies currently has a consensus rating of “Hold”.

Bausch Health Companies Trading Down 11.0%

The company has a market cap of C$2.99 billion, a P/E ratio of 8.32, a P/E/G ratio of 0.21 and a beta of 0.54. The business has a fifty day simple moving average of C$9.55 and a 200 day simple moving average of C$9.38. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported C$0.48 earnings per share (EPS) for the quarter. Bausch Health Companies had a positive return on equity of 15.87% and a negative net margin of 1.88%.The business had revenue of C$2.68 billion for the quarter. Analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.